Setting

North America Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Country: Trend Forecast and Growth Opportunity

Published: 31 Mar 2022 | Report Code: 10248433 | Pages: 130

North America bioanalytical testing services market is projected to grow by 8.3% annually in the forecast period and reach $ 3,232.3 million by 2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach. Highlighted with 29 tables and 75 figures, this 130-page report “North America Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America bioanalytical testing services market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America bioanalytical testing services market in every aspect of the classification from perspectives of Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Country. Based on Molecule Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. Small Molecules Large Molecules LC-MS Studies Immunoassays Other Large Molecule Tests Based Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. Bioavailability and Bioequivalence Studies Pharmacokinetics (PK) Pharmacodynamics (PD) Absorption, Distribution, Metabolism, Excretion (ADME) Other Applications By Test Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. Cell-based Assays Bacterial Cell-based Assays Viral Cell-based Assays Virology Testing In Vitro Virology Testing In Vivo Virology Testing Species-Specific Viral PCR Assays Serology, Immunogenicity, and Neutralizing Antibodies (SINA) Bacterial Serology, Immunogenicity, and Neutralizing Antibodies Viral Serology, Immunogenicity, and Neutralizing Antibodies Method Development Optimization and Validation (MDOV) Biomarker Testing Pharmacokinetic Testing Other Test Types By Workflow Process, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. Sample Preparation Protein Precipitation Liquid-liquid Extraction (LLE) Sample Analysis Hyphenated Technique Chromatographic Technique Electrophoresis Ligand Binding Assay Mass Spectrometry Nuclear Magnetic Resonance Other Workflow Processes By Therapeutic Area, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. Oncology Neurology Infectious Diseases Gastroenterology Cardiology Other Therapeutic Areas By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. Pharma and Biopharma Companies Contract Development and Manufacturing Organizations (CDMOs) Contract Research Organizations (CROs) Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Application, Workflow Process, and Therapeutic Area over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Charles River Laboratories International Inc. Covance Inc. Eurofins Scientific ICON PLC Intertek Group PLC IQVIA Holdings, Inc. Laboratory Corporation of America Holdings Medpace Holdings, Inc. Pace Analytical Services LLC. Parexel International Corporation PPD Inc. SGS SA Syneos Health, LLC Toxikon Corporation WuXi Apptech Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

	8
1.1 Industry Definition and Research Scope	8
1.1.1 Industry Definition	8
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	28
2.3 Market Restraints and Challenges	31
2.4 Emerging Opportunities and Market Trends	34
2.5 Porter’s Fiver Forces Analysis	38
3 Segmentation of North America Market by Molecule Type	42
3.1 Market Overview by Molecule Type	42
3.2 Small Molecules	44
3.3 Large Molecules	45
3.3.1 LC-MS Studies	46
3.3.2 Immunoassays	47
3.3.3 Other Large Molecule Tests	48
4 Segmentation of North America Market by Application	49
4.1 Market Overview by Application	49
4.2 Bioavailability and Bioequivalence Studies	51
4.3 Pharmacokinetics (PK)	52
4.4 Pharmacodynamics (PD)	53
4.5 Absorption, Distribution, Metabolism, Excretion (ADME)	54
4.6 Other Applications	55
5 Segmentation of North America Market by Test Type	56
5.1 Market Overview by Test Type	56
5.2 Cell-based Assays	58
5.2.1 Bacterial Cell-based Assays	59
5.2.2 Viral Cell-based Assays	60
5.3 Virology Testing	61
5.3.1 In Vitro Virology Testing	62
5.3.2 In Vivo Virology Testing	63
5.3.3 Species-Specific Viral PCR Assays	64
5.4 Serology, Immunogenicity, and Neutralizing Antibodies (SINA)	65
5.4.1 Bacterial Serology, Immunogenicity, and Neutralizing Antibodies	66
5.4.2 Viral Serology, Immunogenicity, and Neutralizing Antibodies	67
5.5 Method Development Optimization and Validation (MDOV)	68
5.6 Biomarker Testing	69
5.7 Pharmacokinetic Testing	70
5.8 Other Test Types	71
6 Segmentation of North America Market by Workflow Process	72
6.1 Market Overview by Workflow Process	72
6.2 Sample Preparation	74
6.2.1 Protein Precipitation	75
6.2.2 Liquid-liquid Extraction (LLE)	76
6.2.3 Solid Phase Extraction (SPE)	77
6.3 Sample Analysis	78
6.3.1 Hyphenated Technique	80
6.3.2 Chromatographic Technique	81
6.3.3 Electrophoresis	82
6.3.4 Ligand Binding Assay	83
6.3.5 Mass Spectrometry	84
6.3.6 Nuclear Magnetic Resonance	85
6.4 Other Workflow Processes	86
7 Segmentation of North America Market by Therapeutic Area	87
7.1 Market Overview by Therapeutic Area	87
7.2 Oncology	89
7.3 Neurology	90
7.4 Infectious Diseases	91
7.5 Gastroenterology	92
7.6 Cardiology	93
7.7 Other Therapeutic Areas	94
8 Segmentation of North America Market by End User	95
8.1 Market Overview by End User	95
8.2 Pharma and Biopharma Companies	97
8.3 Contract Development and Manufacturing Organizations (CDMOs)	98
8.4 Contract Research Organizations (CROs)	99
9 North America Market 2021-2031 by Country	100
9.1 Overview of North America Market	100
9.2 U.S.	103
9.3 Canada	106
9.4 Mexico	108
10 Competitive Landscape	110
10.1 Overview of Key Vendors	110
10.2 New Product Launch, Partnership, Investment, and M&A	113
10.3 Company Profiles	114
Charles River Laboratories International Inc.	114
Covance Inc.	116
Eurofins Scientific	117
ICON PLC	118
Intertek Group PLC	119
IQVIA Holdings, Inc.	120
Laboratory Corporation of America Holdings	121
Medpace Holdings, Inc.	122
Pace Analytical Services LLC.	123
Parexel International Corporation	124
PPD Inc.	125
SGS SA	126
Syneos Health, LLC	127
Toxikon Corporation	128
WuXi Apptech Co., Ltd.	129
RELATED REPORTS	130
List Of Tables:


Table 1.  Snapshot of North America Bioanalytical Testing Services Market in Balanced Perspective, 2021-2031	18
Table 2. World Economic Outlook, 2021-2031	22
Table 3. World Health Spending by Region, $ bn, 2013-2020	27
Table 4.  Main Product Trends and Market Opportunities in North America Bioanalytical Testing Services Market	34
Table 5. North America Bioanalytical Testing Services Market by Molecule Type, 2021-2031, $ mn	42
Table 6. North America Bioanalytical Testing Services Market: Large Molecules Testing by Technology, 2021-2031, $ mn	45
Table 7. North America Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	49
Table 8. North America Bioanalytical Testing Services Market by Test Type, 2021-2031, $ mn	56
Table 9. North America Bioanalytical Testing Services Market: Cell-based Assays by Type, 2021-2031, $ mn	58
Table 10. North America Bioanalytical Testing Services Market: Virology Testing by Type, 2021-2031, $ mn	61
Table 11. North America Bioanalytical Testing Services Market: Serology, Immunogenicity, and Neutralizing Antibodies (SINA) by Type, 2021-2031, $ mn	65
Table 12. North America Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	72
Table 13. North America Bioanalytical Testing Services Market: Sample Preparation by Method, 2021-2031, $ mn	74
Table 14. North America Bioanalytical Testing Services Market: Sample Analysis by Technology, 2021-2031, $ mn	79
Table 15. North America Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	87
Table 16. North America Bioanalytical Testing Services Market by End User, 2021-2031, $ mn	95
Table 17. North America Bioanalytical Testing Services Market by Country, 2021-2031, $ mn	101
Table 18. U.S. Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	105
Table 19. U.S. Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	105
Table 20. U.S. Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	105
Table 21. Canada Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	107
Table 22. Canada Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	107
Table 23. Canada Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	107
Table 24. Mexico Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	109
Table 25. Mexico Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	109
Table 26. Mexico Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	109
Table 27. Charles River Laboratories International Inc.: Company Snapshot	114
Table 28. Charles River Laboratories International Inc.: Business Segmentation	115
Table 29. Charles River Laboratories International Inc.: Product Portfolio	115
List Of Figures:


Figure 1. Research Method Flow Chart	12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	17
Figure 4. North America Bioanalytical Testing Services Market, 2021-2031, $ mn	20
Figure 5. Impact of COVID-19 on Business	23
Figure 6.  Leading Causes of Death in the World, 2019-2020, million	25
Figure 7.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	26
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060	26
Figure 9. Primary Drivers and Impact Factors of North America Bioanalytical Testing Services Market	28
Figure 10. Primary Restraints and Impact Factors of North America Bioanalytical Testing Services Market	31
Figure 11. Investment Opportunity Analysis	35
Figure 12. Porter’s Fiver Forces Analysis of North America Bioanalytical Testing Services Market	38
Figure 13. Breakdown of North America Bioanalytical Testing Services Market by Molecule Type, 2021-2031, % of Revenue	43
Figure 14. North America Addressable Market Cap in 2022-2031 by Molecule Type, Value ($ mn) and Share (%)	43
Figure 15. North America Bioanalytical Testing Services Market by Molecule Type: Small Molecules, 2021-2031, $ mn	44
Figure 16. North America Bioanalytical Testing Services Market by Molecule Type: Large Molecules, 2021-2031, $ mn	45
Figure 17. North America Bioanalytical Testing Services Market by Large Molecules: LC-MS Studies, 2021-2031, $ mn	46
Figure 18. North America Bioanalytical Testing Services Market by Large Molecules: Immunoassays, 2021-2031, $ mn	47
Figure 19. North America Bioanalytical Testing Services Market by Large Molecules: Other Large Molecule Tests, 2021-2031, $ mn	48
Figure 20. Breakdown of North America Bioanalytical Testing Services Market by Application, 2021-2031, % of Sales Revenue	50
Figure 21. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	50
Figure 22. North America Bioanalytical Testing Services Market by Application: Bioavailability and Bioequivalence Studies, 2021-2031, $ mn	51
Figure 23. North America Bioanalytical Testing Services Market by Application: Pharmacokinetics (PK), 2021-2031, $ mn	52
Figure 24. North America Bioanalytical Testing Services Market by Application: Pharmacodynamics (PD), 2021-2031, $ mn	53
Figure 25. North America Bioanalytical Testing Services Market by Application: Absorption, Distribution, Metabolism, Excretion (ADME), 2021-2031, $ mn	54
Figure 26. North America Bioanalytical Testing Services Market by Application: Other Applications, 2021-2031, $ mn	55
Figure 27. Breakdown of North America Bioanalytical Testing Services Market by Test Type, 2021-2031, % of Sales Revenue	57
Figure 28. North America Addressable Market Cap in 2022-2031 by Test Type, Value ($ mn) and Share (%)	57
Figure 29. North America Bioanalytical Testing Services Market by Test Type: Cell-based Assays, 2021-2031, $ mn	58
Figure 30. North America Bioanalytical Testing Services Market by Cell-based Assays: Bacterial Cell-based Assays, 2021-2031, $ mn	59
Figure 31. North America Bioanalytical Testing Services Market by Cell-based Assays: Viral Cell-based Assays, 2021-2031, $ mn	60
Figure 32. North America Bioanalytical Testing Services Market by Test Type: Virology Testing, 2021-2031, $ mn	61
Figure 33. North America Bioanalytical Testing Services Market by Virology Testing: In Vitro Virology Testing, 2021-2031, $ mn	62
Figure 34. North America Bioanalytical Testing Services Market by Virology Testing: In Vivo Virology Testing, 2021-2031, $ mn	63
Figure 35. North America Bioanalytical Testing Services Market by Virology Testing: Species-Specific Viral PCR Assays, 2021-2031, $ mn	64
Figure 36. North America Bioanalytical Testing Services Market by Test Type: Serology, Immunogenicity, and Neutralizing Antibodies (SINA), 2021-2031, $ mn	65
Figure 37. North America Bioanalytical Testing Services Market by Serology, Immunogenicity, and Neutralizing Antibodies (SINA): Bacterial Serology, Immunogenicity, and Neutralizing Antibodies, 2021-2031, $ mn	66
Figure 38. North America Bioanalytical Testing Services Market by Serology, Immunogenicity, and Neutralizing Antibodies (SINA): Viral Serology, Immunogenicity, and Neutralizing Antibodies, 2021-2031, $ mn	67
Figure 39. North America Bioanalytical Testing Services Market by Test Type: Method Development Optimization and Validation (MDOV), 2021-2031, $ mn	68
Figure 40. North America Bioanalytical Testing Services Market by Test Type: Biomarker Testing, 2021-2031, $ mn	69
Figure 41. North America Bioanalytical Testing Services Market by Test Type: Pharmacokinetic Testing, 2021-2031, $ mn	70
Figure 42. North America Bioanalytical Testing Services Market by Test Type: Other Test Types, 2021-2031, $ mn	71
Figure 43. Breakdown of North America Bioanalytical Testing Services Market by Workflow Process, 2021-2031, % of Revenue	73
Figure 44. North America Addressable Market Cap in 2022-2031 by Workflow Process, Value ($ mn) and Share (%)	73
Figure 45. North America Bioanalytical Testing Services Market by Workflow Process: Sample Preparation, 2021-2031, $ mn	74
Figure 46. North America Bioanalytical Testing Services Market by Sample Preparation: Protein Precipitation, 2021-2031, $ mn	75
Figure 47. North America Bioanalytical Testing Services Market by Sample Preparation: Liquid-liquid Extraction (LLE), 2021-2031, $ mn	76
Figure 48. North America Bioanalytical Testing Services Market by Sample Preparation: Solid Phase Extraction (SPE), 2021-2031, $ mn	77
Figure 49. North America Bioanalytical Testing Services Market by Workflow Process: Sample Analysis, 2021-2031, $ mn	78
Figure 50. North America Bioanalytical Testing Services Market by Sample Analysis: Hyphenated Technique, 2021-2031, $ mn	80
Figure 51. North America Bioanalytical Testing Services Market by Sample Analysis: Chromatographic Technique, 2021-2031, $ mn	81
Figure 52. North America Bioanalytical Testing Services Market by Sample Analysis: Electrophoresis, 2021-2031, $ mn	82
Figure 53. North America Bioanalytical Testing Services Market by Sample Analysis: Ligand Binding Assay, 2021-2031, $ mn	83
Figure 54. North America Bioanalytical Testing Services Market by Sample Analysis: Mass Spectrometry, 2021-2031, $ mn	84
Figure 55. North America Bioanalytical Testing Services Market by Sample Analysis: Nuclear Magnetic Resonance, 2021-2031, $ mn	85
Figure 56. North America Bioanalytical Testing Services Market by Workflow Process: Other Workflow Processes, 2021-2031, $ mn	86
Figure 57. Breakdown of North America Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, % of Revenue	88
Figure 58. North America Addressable Market Cap in 2022-2031 by Therapeutic Area, Value ($ mn) and Share (%)	88
Figure 59. North America Bioanalytical Testing Services Market by Therapeutic Area: Oncology, 2021-2031, $ mn	89
Figure 60. North America Bioanalytical Testing Services Market by Therapeutic Area: Neurology, 2021-2031, $ mn	90
Figure 61. North America Bioanalytical Testing Services Market by Therapeutic Area: Infectious Diseases, 2021-2031, $ mn	91
Figure 62. North America Bioanalytical Testing Services Market by Therapeutic Area: Gastroenterology, 2021-2031, $ mn	92
Figure 63. North America Bioanalytical Testing Services Market by Therapeutic Area: Cardiology, 2021-2031, $ mn	93
Figure 64. North America Bioanalytical Testing Services Market by Therapeutic Area: Other Therapeutic Areas, 2021-2031, $ mn	94
Figure 65. Breakdown of North America Bioanalytical Testing Services Market by End User, 2021-2031, % of Revenue	95
Figure 66. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	96
Figure 67. North America Bioanalytical Testing Services Market by End User: Pharma and Biopharma Companies, 2021-2031, $ mn	97
Figure 68. North America Bioanalytical Testing Services Market by End User: Contract Development and Manufacturing Organizations (CDMOs), 2021-2031, $ mn	98
Figure 69. North America Bioanalytical Testing Services Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn	99
Figure 70. Breakdown of North America Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue	101
Figure 71. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	102
Figure 72. U.S. Bioanalytical Testing Services Market, 2021-2031, $ mn	104
Figure 73. Canada Bioanalytical Testing Services Market, 2021-2031, $ mn	106
Figure 74.  Bioanalytical Testing Services Market in Mexico, 2021-2031, $ mn	108
Figure 75. Growth Stage of North America Bioanalytical Testing Services Industry over the Forecast Period	110
Selected Key Players: 
Charles River Laboratories International Inc.
Covance Inc.
Eurofins Scientific
ICON PLC
Intertek Group PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America Holdings
Medpace Holdings, Inc.
Pace Analytical Services LLC.
Parexel International Corporation
PPD Inc.
SGS SA
Syneos Health, LLC
Toxikon Corporation
WuXi Apptech Co., Ltd. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)